Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S C Gilbert

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Science (New York, N.Y.)|March 21, 1998
Association of malaria parasite population structure, HLA, and immunological antagonismS C Gilbert, M Plebanski, S Gupta, et al.
The Journal of General Virology|February 14, 1998
Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in miceT Hanke, T J Blanchard, J Schneider, et al.
Nature|July 20, 1995
Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malariaC Ruwende, S C Khoo, R W Snow, et al.
European Journal of Immunology|December 23, 1998
Protection from Plasmodium berghei infection by priming and boosting T cells to a single class I-restricted epitope with recombinant carriers suitable for human useM Plebanski, S C Gilbert, J Schneider, et al.
QJM : Monthly Journal of the Association of Physicians|March 31, 1998
Mannose binding protein deficiency is not associated with malaria, hepatitis B carriage nor tuberculosis in AfricansR Bellamy, C Ruwende, K P McAdam, et al.
Caries Research|December 14, 2004
The microflora of the erupting first permanent molarS R Brailsford, E C Sheehy, S C Gilbert, et al.
Nature Medicine|April 18, 1998
Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus AnkaraJ Schneider, S C Gilbert, T J Blanchard, et al.
Vaccine|February 21, 2006
Safety of recombinant fowlpox strain FP9 and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteersD P Webster, S Dunachie, S McConkey, et al.
Vaccine|April 23, 2003
Safety of DNA and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteersV S Moorthy, S McConkey, M Roberts, et al.
Developments in Biologicals|November 21, 2001
DNA-based vaccines for malaria: a heterologous prime-boost immunisation strategyA V Hill, W Reece, P Gothard, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Science (New York, N.Y.)|March 21, 1998
Association of malaria parasite population structure, HLA, and immunological antagonismS C Gilbert, M Plebanski, S Gupta, et al.
The Journal of General Virology|February 14, 1998
Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in miceT Hanke, T J Blanchard, J Schneider, et al.
Nature|July 20, 1995
Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malariaC Ruwende, S C Khoo, R W Snow, et al.
European Journal of Immunology|December 23, 1998
Protection from Plasmodium berghei infection by priming and boosting T cells to a single class I-restricted epitope with recombinant carriers suitable for human useM Plebanski, S C Gilbert, J Schneider, et al.
QJM : Monthly Journal of the Association of Physicians|March 31, 1998
Mannose binding protein deficiency is not associated with malaria, hepatitis B carriage nor tuberculosis in AfricansR Bellamy, C Ruwende, K P McAdam, et al.
Caries Research|December 14, 2004
The microflora of the erupting first permanent molarS R Brailsford, E C Sheehy, S C Gilbert, et al.
Nature Medicine|April 18, 1998
Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus AnkaraJ Schneider, S C Gilbert, T J Blanchard, et al.
Vaccine|February 21, 2006
Safety of recombinant fowlpox strain FP9 and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteersD P Webster, S Dunachie, S McConkey, et al.
Vaccine|April 23, 2003
Safety of DNA and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteersV S Moorthy, S McConkey, M Roberts, et al.
Developments in Biologicals|November 21, 2001
DNA-based vaccines for malaria: a heterologous prime-boost immunisation strategyA V Hill, W Reece, P Gothard, et al.
Pageof 6